northeast_georgia_medical_center_oncology_annual_r.pdf
NGMC Acquires HistoSonics Device for Liver Tumor Therapy
Trusted by teams at
Description
Northeast Georgia Medical Center purchased a histotripsy unit from HistoSonics in April 2024, deploying the first-of-its-kind, FDA-approved device for non-invasive liver tumor therapy. More than 60 patients have been treated since its adoption.
Contract Details
Vendor
HISTOSONICS
Agency
Northeast Georgia Medical Center, Inc, GA
Contract Type
EQUIPMENT
Document Date
January 1, 2024
More from HISTOSONICS
Related Contracts
texas-tech-university-system-board-of-regents-meeting-agenda-november-14-2025_5b9.pdf
pendingTexas Tech University System Board of Regents Minutes November 14 2025
APPROVEDTexas Tech University System Board of Regents Minutes November 14 2025
APPROVEDtexas-tech-university-system-board-of-regents-agenda-november-14-2025_3f4.pdf
APPROVEDcity_of_plymouth_community_and_economic_developmen.pdf
APPROVEDIssuing Agency
Northeast Georgia Medical Center, Inc
Public Hospital
Gainesville, GA
More from Northeast Georgia Medical Center, Inc
northeast_georgia_regional_community_health_needs.pdf
northeast_georgia_community_health_needs_assessmen.pdf
northeast_georgia_regional_community_health_needs.pdf
northeast_georgia_community_health_needs_assessmen.pdf
northeast_georgia_medical_center_oncology_annual_r.pdf
Want to learn more?
Get alerts on contract renewals, new awards, and vendor activity.
Bring us your territory.
We'll show you what is forming.
See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.